文献速递间质性肺疾病

美国特发性肺纤维化死亡率趋势:2004年至2017年

Mortality Trends of Idiopathic Pulmonary Fibrosis in the United States From 2004 Through 2017.
PubMed 文献 · Chest · 2020-08-14

该研究基于美国疾病控制与预防中心的多死因数据库,分析了2004年至2017年间特发性肺纤维化(IPF)相关死亡率的趋势。结果显示,年龄调整死亡率在男性中下降4.1%,女性下降13.4%,整体下降主要由85岁以下患者驱动,但白人男性死亡率保持稳定。死亡地点从住院和养老院向家庭和临终关怀机构转移。

要点

  • 2004-2017年美国IPF年龄调整死亡率整体下降,女性降幅大于男性。
  • 白人男性IPF死亡率保持稳定,是唯一未下降的亚组。
  • 死亡地点从住院和养老院向家庭和临终关怀机构转移。

核心结论

  • 2004年至2017年美国IPF年龄调整死亡率下降,部分可能归因于吸烟减少,但需进一步研究其他环境与遗传因素。

研究设计与样本

  • 研究使用美国疾病控制与预防中心网站的多死因数据库,涵盖所有已故美国居民,通过ICD-10编码识别IPF相关死亡。
  • 分析按年龄、性别、种族和居住州分层的年龄调整死亡率年度趋势,并评估死亡地点和根本死因的趋势。

主要发现

  • 2004年至2017年,男性年龄调整死亡率从75.5例/100万降至72.4例/100万,下降4.1%;女性从46.3例/100万降至40.1例/100万,下降13.4%。
  • 整体下降主要由85岁以下患者IPF相关死亡率下降驱动。
  • 除白人男性外,所有种族均观察到下降趋势,白人男性死亡率保持稳定。
  • 最常见的根本死因为肺纤维化。
  • 住院和养老院死亡比例下降,而家庭和临终关怀机构死亡比例上升。

临床怎么用

  • 临床医生应了解IPF死亡率总体下降趋势,但需关注白人男性死亡率未下降的现象。
  • 死亡地点向家庭和临终关怀转移提示需加强相应终末期照护资源配置。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The burden of idiopathic pulmonary fibrosis (IPF)-related mortality in the United States in recent years is not well characterized. RESEARCH QUESTION: What are the trends in IPF-related mortality rates in the United States from 2004 through 2017? STUDY DESIGN AND METHODS: We used the Multiple Cause of Death Database available through the Centers for Disease Control and Prevention website, which contains data from all deceased US residents. IPF-related deaths were identified using International Classification of Diseases, 10th revision, codes. We examined annual trends in age-adjusted mortality rates stratified by age, sex, race, and state of residence. We also evaluated trends in place of death and underlying cause of death. RESULTS: From 2004 through 2017, the age-adjusted mortality decreased by 4.1% in men (from 75.5 deaths/1,000,000 in 2004 to 72.4 deaths/1,000,000 in 2017) and by 13.4% in women (from 46.3 deaths/1,000,000 in 2004 to 40.1 deaths/1,000,000 in 2017). This overall decrease was driven mainly by a decline in IPF-related mortality in patients younger than 85 years. The decreasing trend also was noted in all races except White men, in whom the rate remained stable. The most common cause of death was pulmonary fibrosis. The percentage of deaths occurring in the inpatient setting and nursing homes decreased, whereas the percentage of deaths occurring at home and hospice increased. INTERPRETATION: From 2004 through 2017, the IPF age-adjusted mortality rates decreased. This may be explained partly by a decline in smoking in the United States, but further research is needed to evaluate other environmental and genetic contributors.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Jeganathan N, Smith RA, Sathananthan M, et al. Mortality Trends of Idiopathic Pulmonary Fibrosis in the United States From 2004 Through 2017. Chest. 2020. PMID: 32805236. doi:10.1016/j.chest.2020.08.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。